|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
22 March 2021 |
|
Main ID: |
NCT04800055 |
|
Date of registration:
|
12/03/2021 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Attractive Targeted Sugar Bait Phase III Trial in Zambia
|
|
Scientific title:
|
Attractive Targeted Sugar Bait Phase III Trial in Zambia |
|
Date of first enrolment:
|
December 1, 2020 |
|
Target sample size:
|
3480 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT04800055 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Zambia
| | | | | | | |
|
Contacts
|
|
Name:
|
Kafula Silumbe, MPH |
|
Address:
|
|
|
Telephone:
|
+260978774230 |
|
Email:
|
ksilumbe@path.org |
|
Affiliation:
|
|
|
|
Name:
|
John M Miller, PhD |
|
Address:
|
|
|
Telephone:
|
+260977510414 |
|
Email:
|
jmiller@path.org |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Household resident
- =12 months and <15 years of age at the time of enrollment
- If age 12 months - 6 years of age, parent or guardian provides consent for child's
participant
- If age 7-14 years, parent or guardian provides consent for child's participant and
child provides assent for participation
Exclusion Criteria:
- Residence within the buffer zone
- Age <12 months or =15 years of age at the time of cohort enrollment
- Household contained a participant in the first cohort (for participation in the second
cohort)
- Pregnant at the time of cohort enrollment. Pregnant adolescents are excluded because
they are eligible for protection from infection through pregnancy standard of care -
intermittent preventative therapy during pregnancy (IPTp), and to avoid undue
discomfort with repeated blood sampling.
- Pregnancy at any time during the cohort study. Pregnancy will be identified in
adolescents at enrollment and follow-up visits through a single question regarding
pregnancy status during each cohort visit. When an adolescent indicates that she is
pregnant or is unsure of her pregnancy status, she will no longer be followed for
ongoing blood testing for the reasons noted above and will be censored in the
analysis.
- Does not provide consent/assent required according to age to participate in the study
Age minimum:
12 Months
Age maximum:
15 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Malaria
|
|
Malaria,Falciparum
|
|
Vector-Borne Transmission of Infection
|
|
Intervention(s)
|
|
Other: Attractive Targeted Sugar Bait
|
|
Primary Outcome(s)
|
|
Clinical malaria case incidence
[Time Frame: Seasonal (6 months)]
|
|
Secondary Outcome(s)
|
|
Incidence rate of passively reported clinical malaria
[Time Frame: Seasonal (6 months)]
|
|
Prevalence, detected by PCR
[Time Frame: 6 weeks]
|
|
Prevalence, detected by RDT
[Time Frame: 6 weeks]
|
|
Time to first infection
[Time Frame: Seasonal (6 months)]
|
|
Secondary ID(s)
|
|
1460046
|
|
1460046-5
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|